Michael Bruce
Amministratore Delegato presso Exo Therapeutics, Inc.
Posizioni attive di Michael Bruce
Società | Posizione | Inizio | Fine |
---|---|---|---|
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Amministratore Delegato | 01/02/2020 | - |
Storia della carriera di Michael Bruce
Precedenti posizioni note di Michael Bruce
Società | Posizione | Inizio | Fine |
---|---|---|---|
KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01/10/2017 | 01/02/2020 |
CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01/01/2015 | 01/01/2017 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | 01/01/2003 | 01/01/2015 |
PFIZER, INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2015 |
Formazione di Michael Bruce
Williams College | Undergraduate Degree |
Stanford University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Svizzera | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
KALEIDO BIOSCIENCES, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Aziende private | 2 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael Bruce
- Esperienza